Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression

Treatment options for chronically aggressive individuals remain limited despite recent medical advances. Traditional pharmacological agents used to treat aggression, such as atypical antipsychotics, have limited efficacy and are often replete with dangerous side effects. The non-competitive NMDAR an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartsch, Caitlyn J., Nordman, Jacob C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Behavioral Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253591/
https://www.ncbi.nlm.nih.gov/pubmed/35801096
http://dx.doi.org/10.3389/fnbeh.2022.938044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253591/
https://www.ncbi.nlm.nih.gov/pubmed/35801096
http://dx.doi.org/10.3389/fnbeh.2022.938044

Ejemplares similares